Methodology

All entries for: Monte Rosa Therapeutics

March 17, 2026

Monte Rosa Therapeutics

Neutral Outlook

Boston, MA
51-200 employees

The effect of IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Immune Diseases, Oncology
Drug Type: Small Molecule
Source
Source
Scroll to Top